Taylor, Cottrill, Erickson & Associates, Inc. Cerus Corp Transaction History
Taylor, Cottrill, Erickson & Associates, Inc.
- $338 Million
- Q2 2024
A detailed history of Taylor, Cottrill, Erickson & Associates, Inc. transactions in Cerus Corp stock. As of the latest transaction made, Taylor, Cottrill, Erickson & Associates, Inc. holds 29,049 shares of CERS stock, worth $50,835. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,049
Previous 29,049
-0.0%
Holding current value
$50,835
Previous $54,000
5.56%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding CERS
# of Institutions
149Shares Held
147MCall Options Held
191KPut Options Held
43.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl19.9MShares$34.8 Million0.32% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$34.1 Million0.46% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$24.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$18.3 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.58MShares$15 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $310M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...